# Aramark: financial statements, quarterly

ARMK · NYSE · CIK 1584509 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Oct 2

Pages: [Overview](/companies/armk.md) · [Financials](/companies/armk/financials.md) · [Filings](/companies/armk/filings.md) · [Insiders](/companies/armk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/armk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,200 d](/filings/0001584509-25-000219.md) | [4,408](/filings/0001584509-25-000053.md) | [4,200](/filings/0001584509-25-000118.md) | [4,376](/filings/0001584509-25-000169.md) | [4,417 d](/filings/0001584509-25-000219.md) | [4,552](/filings/0001584509-26-000040.md) | [4,279](/filings/0001584509-26-000088.md) | [4,626](/filings/0001584509-26-000122.md) | [5,048 d](/filings/0001584509-25-000219.md) | [4,832](/filings/0001584509-26-000040.md) | [4,907](/filings/0001584509-26-000088.md) | [5,058](/filings/0001584509-26-000122.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [75.1 d](/filings/0001584509-25-000219.md) | [90.2](/filings/0001584509-25-000053.md) | [62.6](/filings/0001584509-25-000118.md) | [65.4](/filings/0001584509-25-000169.md) | [65.5 d](/filings/0001584509-25-000219.md) | [70.4](/filings/0001584509-26-000040.md) | [68.4](/filings/0001584509-26-000088.md) | [65.7](/filings/0001584509-26-000122.md) | [73.9 d](/filings/0001584509-25-000219.md) | [72.7](/filings/0001584509-26-000040.md) | [74.5](/filings/0001584509-26-000088.md) | [78.6](/filings/0001584509-26-000122.md) |
| Operating income | $m | [215 d](/filings/0001584509-25-000219.md) | [167](/filings/0001584509-25-000053.md) | [159](/filings/0001584509-25-000118.md) | [162](/filings/0001584509-25-000169.md) | [219 d](/filings/0001584509-25-000219.md) | [217](/filings/0001584509-26-000040.md) | [174](/filings/0001584509-26-000088.md) | [183](/filings/0001584509-26-000122.md) | [218 d](/filings/0001584509-25-000219.md) | [218](/filings/0001584509-26-000040.md) | [220](/filings/0001584509-26-000088.md) | [216](/filings/0001584509-26-000122.md) |
| Interest expense | $m | [114 d](/filings/0001584509-23-000237.md) | [115](/filings/0001584509-24-000047.md) | [86.4](/filings/0001584509-24-000097.md) | [81.5](/filings/0001584509-24-000153.md) | [107 d](/filings/0001584509-25-000219.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(3.5) d](/filings/0001584509-25-000219.md) | [23.9](/filings/0001584509-25-000053.md) | [19.7](/filings/0001584509-25-000118.md) | [22.1](/filings/0001584509-25-000169.md) | [37.3 d](/filings/0001584509-25-000219.md) | [35.8](/filings/0001584509-26-000040.md) | [22.5](/filings/0001584509-26-000088.md) | [24.2](/filings/0001584509-26-000122.md) | [21.1 d](/filings/0001584509-25-000219.md) | [39.1](/filings/0001584509-26-000040.md) | [35.4](/filings/0001584509-26-000088.md) | [37.9](/filings/0001584509-26-000122.md) |
| Net income | $m | [205 d](/filings/0001584509-25-000219.md) | [28.5](/filings/0001584509-25-000169.md) | [53.4](/filings/0001584509-25-000169.md) | [58.1](/filings/0001584509-25-000169.md) | [122 d](/filings/0001584509-25-000219.md) | [106](/filings/0001584509-26-000122.md) | [61.9](/filings/0001584509-26-000122.md) | [71.8](/filings/0001584509-26-000122.md) | [87.1 d](/filings/0001584509-25-000219.md) | [96.2](/filings/0001584509-26-000122.md) | [102](/filings/0001584509-26-000122.md) | [97.7](/filings/0001584509-26-000122.md) |
| Diluted EPS | $ per share | not reported | [0.11](/filings/0001584509-25-000053.md) | [0.20](/filings/0001584509-25-000118.md) | [0.22](/filings/0001584509-25-000169.md) | not reported | [0.39](/filings/0001584509-26-000040.md) | [0.23](/filings/0001584509-26-000088.md) | [0.27](/filings/0001584509-26-000122.md) | not reported | [0.36](/filings/0001584509-26-000040.md) | [0.38](/filings/0001584509-26-000088.md) | [0.36](/filings/0001584509-26-000122.md) |
| Basic EPS | $ per share | not reported | [0.11](/filings/0001584509-25-000053.md) | [0.20](/filings/0001584509-25-000118.md) | [0.22](/filings/0001584509-25-000169.md) | not reported | [0.40](/filings/0001584509-26-000040.md) | [0.23](/filings/0001584509-26-000088.md) | [0.27](/filings/0001584509-26-000122.md) | not reported | [0.37](/filings/0001584509-26-000040.md) | [0.39](/filings/0001584509-26-000088.md) | [0.37](/filings/0001584509-26-000122.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.9](/filings/0001584509-25-000219.md) | [0.3](/filings/0001584509-25-000053.md) | [0.4](/filings/0001584509-25-000118.md) | [0.4](/filings/0001584509-25-000169.md) | [0.7](/filings/0001584509-25-000219.md) | [0.5](/filings/0001584509-26-000040.md) | [0.9](/filings/0001584509-26-000088.md) | [0.5](/filings/0001584509-26-000122.md) | [0.6](/filings/0001584509-26-000122.md) | [0.4](/filings/0001584509-26-000040.md) | [0.5](/filings/0001584509-26-000088.md) | [0.5](/filings/0001584509-26-000122.md) |
| Current assets | $bn | [5.2](/filings/0001584509-24-000212.md) | [3.2](/filings/0001584509-24-000047.md) | [3.3](/filings/0001584509-24-000097.md) | [3.3](/filings/0001584509-24-000153.md) | [3.4](/filings/0001584509-25-000219.md) | [3.3](/filings/0001584509-25-000053.md) | [3.8](/filings/0001584509-25-000118.md) | [3.5](/filings/0001584509-25-000169.md) | [3.5](/filings/0001584509-26-000122.md) | [3.6](/filings/0001584509-26-000040.md) | [3.7](/filings/0001584509-26-000088.md) | [3.9](/filings/0001584509-26-000122.md) |
| Total assets | $bn | [16.9](/filings/0001584509-24-000212.md) | [12.4](/filings/0001584509-24-000047.md) | [12.6](/filings/0001584509-24-000097.md) | [12.5](/filings/0001584509-24-000153.md) | [12.7](/filings/0001584509-25-000219.md) | [12.7](/filings/0001584509-25-000053.md) | [13.5](/filings/0001584509-25-000118.md) | [13.3](/filings/0001584509-25-000169.md) | [13.3](/filings/0001584509-26-000122.md) | [13.5](/filings/0001584509-26-000040.md) | [13.8](/filings/0001584509-26-000088.md) | [14.0](/filings/0001584509-26-000122.md) |
| Current liabilities | $bn | [5.0](/filings/0001584509-24-000212.md) | [2.5](/filings/0001584509-24-000047.md) | [2.7](/filings/0001584509-24-000097.md) | [3.5](/filings/0001584509-24-000153.md) | [4.2](/filings/0001584509-25-000219.md) | [3.5](/filings/0001584509-25-000053.md) | [3.2](/filings/0001584509-25-000118.md) | [2.7](/filings/0001584509-25-000169.md) | [3.5](/filings/0001584509-26-000122.md) | [2.9](/filings/0001584509-26-000040.md) | [3.1](/filings/0001584509-26-000088.md) | [3.0](/filings/0001584509-26-000122.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [1.6](/filings/0001584509-23-000237.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.7](/filings/0001584509-25-000219.md) | [2.8](/filings/0001584509-25-000169.md) | [2.9](/filings/0001584509-25-000169.md) | [2.9](/filings/0001584509-25-000169.md) | [3.0](/filings/0001584509-26-000122.md) | [3.1](/filings/0001584509-26-000122.md) | [3.0](/filings/0001584509-26-000122.md) | [3.1](/filings/0001584509-26-000122.md) | [3.1](/filings/0001584509-26-000122.md) | [3.2](/filings/0001584509-26-000122.md) | [3.3](/filings/0001584509-26-000122.md) | [3.4](/filings/0001584509-26-000122.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-29) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q4 FY2024 (2024-09-27) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q4 FY2025 (2025-10-03) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,037 d](/filings/0001584509-23-000237.md) | [(657)](/filings/0001584509-25-000053.md) | [221 d](/filings/0001584509-25-000118.md) | [141 d](/filings/0001584509-25-000169.md) | [1,022 d](/filings/0001584509-25-000219.md) | [(587)](/filings/0001584509-26-000040.md) | [256 d](/filings/0001584509-26-000088.md) | [76.7 d](/filings/0001584509-26-000122.md) | [1,176 d](/filings/0001584509-25-000219.md) | [(782)](/filings/0001584509-26-000040.md) | [400 d](/filings/0001584509-26-000088.md) | [117 d](/filings/0001584509-26-000122.md) |
| Capital expenditure | $m | [125 d](/filings/0001584509-25-000219.md) | [116](/filings/0001584509-25-000053.md) | [87.4 d](/filings/0001584509-25-000118.md) | [85.1 d](/filings/0001584509-25-000169.md) | [139 d](/filings/0001584509-25-000219.md) | [120](/filings/0001584509-26-000040.md) | [116 d](/filings/0001584509-26-000088.md) | [111 d](/filings/0001584509-26-000122.md) | [142 d](/filings/0001584509-25-000219.md) | [122](/filings/0001584509-26-000040.md) | [101 d](/filings/0001584509-26-000088.md) | [112 d](/filings/0001584509-26-000122.md) |
| Dividends paid | $m | [28.7 d](/filings/0001584509-25-000219.md) | [24.9](/filings/0001584509-25-000053.md) | [24.9 d](/filings/0001584509-25-000118.md) | [25.0 d](/filings/0001584509-25-000169.md) | [25.0 d](/filings/0001584509-25-000219.md) | [27.9](/filings/0001584509-26-000040.md) | [27.8 d](/filings/0001584509-26-000088.md) | [27.5 d](/filings/0001584509-26-000122.md) | [27.6 d](/filings/0001584509-25-000219.md) | [31.5](/filings/0001584509-26-000040.md) | [31.5 d](/filings/0001584509-26-000088.md) | [31.6 d](/filings/0001584509-26-000122.md) |
| Share repurchases | $m | not reported | not reported | not reported | [0.0 d](/filings/0001584509-25-000169.md) | [14.4 d](/filings/0001584509-25-000219.md) | [28.6](/filings/0001584509-26-000040.md) | [80.7 d](/filings/0001584509-26-000088.md) | [30.9 d](/filings/0001584509-26-000122.md) | [29.7 d](/filings/0001584509-25-000219.md) | [41.3](/filings/0001584509-26-000040.md) | [25.1 d](/filings/0001584509-26-000088.md) | [0.9 d](/filings/0001584509-26-000122.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-30) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-29) | Q2 FY2024 (2024-03-29) | Q3 FY2024 (2024-06-28) | Q1 FY2025 (2024-12-27) | Q2 FY2025 (2025-03-28) | Q3 FY2025 (2025-06-27) | Q1 FY2026 (2026-01-02) | Q2 FY2026 (2026-04-03) | Q3 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [261](/filings/0001584509-24-000047.md) | [263](/filings/0001584509-24-000097.md) | [263](/filings/0001584509-24-000153.md) | [264](/filings/0001584509-25-000053.md) | [265](/filings/0001584509-25-000118.md) | [267](/filings/0001584509-25-000169.md) | [269](/filings/0001584509-26-000040.md) | [267](/filings/0001584509-26-000088.md) | [265](/filings/0001584509-26-000122.md) | [266](/filings/0001584509-26-000040.md) | [266](/filings/0001584509-26-000088.md) | [269](/filings/0001584509-26-000122.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 263,625,044 at 2026-07-31, from the cover of the [10-Q filed 2026-08-11](/filings/0001584509-26-000122.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.